
Imago BioSciences, Inc. – NASDAQ:IMGO
Imago BioSciences stock price today
Imago BioSciences stock price monthly change
Imago BioSciences stock price quarterly change
Imago BioSciences stock price yearly change
Imago BioSciences key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -19.72 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 7.04 |
PEG ratio | 0.14 |
EPS | -1.85 |
Revenue | N/A |
EBITDA | -62.12M |
Income | -62.62M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImago BioSciences stock price history
Imago BioSciences stock forecast
Imago BioSciences financial statements
Dec 2021 | 0 | -14.72M | |
---|---|---|---|
Mar 2022 | 0 | -16.45M | |
Jun 2022 | 0 | -13.88M | |
Sep 2022 | 0 | -17.54M |
2022-05-12 | -0.42 | -0.49 |
---|---|---|
2022-08-12 | -0.5 | -0.41 |
2022-11-09 | -0.44 | -0.5 |
Dec 2021 | 224786000 | 10.09M | 4.49% |
---|---|---|---|
Mar 2022 | 212446000 | 12.93M | 6.09% |
Jun 2022 | 196111000 | 8.77M | 4.47% |
Sep 2022 | 186457000 | 13.83M | 7.42% |
Dec 2021 | -13.29M | -61.08M | 390K |
---|---|---|---|
Mar 2022 | -11.52M | 8.09M | 454K |
Jun 2022 | -15.76M | 30.26M | 17K |
Sep 2022 | -11.71M | -3.28M | -475K |
Imago BioSciences alternative data
Aug 2023 | 41 |
---|---|
Sep 2023 | 41 |
Oct 2023 | 41 |
Nov 2023 | 41 |
Dec 2023 | 41 |
Jan 2024 | 41 |
Feb 2024 | 41 |
Mar 2024 | 41 |
Apr 2024 | 41 |
May 2024 | 41 |
Jun 2024 | 41 |
Jul 2024 | 41 |
Imago BioSciences other data
Period | Buy | Sel |
---|---|---|
Jan 2022 | 0 | 28000 |
Feb 2022 | 0 | 58500 |
Jul 2022 | 0 | 1750 |
Aug 2022 | 0 | 25603 |
Nov 2022 | 0 | 1303 |
Dec 2022 | 0 | 940889 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | CHIANG HSIANGYI officer: Senior Vice President .. | Stock Option (Right to Buy) | 19,941 | $4.2 | $83,752 | ||
Option | CHIANG HSIANGYI officer: Senior Vice President .. | Common Stock | 19,941 | $4.2 | $83,752 | ||
Option | RIENHOFF HUGH JR director, officer.. | Stock Option (Right to Buy) | 7,415 | $2.52 | $18,686 | ||
Option | RIENHOFF HUGH JR director, officer.. | Common Stock | 7,415 | $2.52 | $18,686 | ||
Option | RIENHOFF HUGH JR director, officer.. | Common Stock | 4,761 | $2.52 | $11,998 | ||
Option | TAPPER AMY E. officer: | Stock Option (Right to Buy) | 1,379 | $22.76 | $31,386 | ||
Option | TAPPER AMY E. officer: | Stock Option (Right to Buy) | 12,400 | $4.2 | $52,080 | ||
Option | TAPPER AMY E. officer: | Stock Option (Right to buy) | 7,482 | $2.52 | $18,855 | ||
Option | TAPPER AMY E. officer: | Common Stock | 1,379 | $22.76 | $31,386 | ||
Option | TAPPER AMY E. officer: | Common Stock | 12,400 | $4.2 | $52,080 |
-
What's the price of Imago BioSciences stock today?
One share of Imago BioSciences stock can currently be purchased for approximately $36.01.
-
When is Imago BioSciences's next earnings date?
Unfortunately, Imago BioSciences's (IMGO) next earnings date is currently unknown.
-
Does Imago BioSciences pay dividends?
No, Imago BioSciences does not pay dividends.
-
What is Imago BioSciences's stock symbol?
Imago BioSciences, Inc. is traded on the NASDAQ under the ticker symbol "IMGO".
-
What is Imago BioSciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Imago BioSciences?
Shares of Imago BioSciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Imago BioSciences's key executives?
Imago BioSciences's management team includes the following people:
- Dr. Hugh Young Rienhoff Jr. Chief Executive Officer & Director(age: 72, pay: $530,920)
- Dr. Amy E. Tapper Ph.D. Senior Vice President of Chemistry, Manufacturing & Controls and Non-Clinical Devel.(age: 54, pay: $352,080)
- Ms. Jennifer Peppe Senior Vice President of Clinical Operations(age: 54, pay: $346,980)
-
How many employees does Imago BioSciences have?
As Jul 2024, Imago BioSciences employs 41 workers.
-
When Imago BioSciences went public?
Imago BioSciences, Inc. is publicly traded company for more then 4 years since IPO on 16 Jul 2021.
-
What is Imago BioSciences's official website?
The official website for Imago BioSciences is imagobio.com.
-
Where are Imago BioSciences's headquarters?
Imago BioSciences is headquartered at 329 Oyster Point Boulevard, South San Francisco, CA.
-
How can i contact Imago BioSciences?
Imago BioSciences's mailing address is 329 Oyster Point Boulevard, South San Francisco, CA and company can be reached via phone at +41 55295055.
Imago BioSciences company profile:

Imago BioSciences, Inc.
imagobio.comNASDAQ
41
Biotechnology
Healthcare
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
South San Francisco, CA 94080
CIK: 0001623715
ISIN: US45250K1079
CUSIP: 45250K107